Pericarditis Market Competitive Landscape 2024-2033 – Major Players and Strategies

Overview and Scope

Pericarditis refers to inflammation and irritation of the thin, saclike tissue called pericardium that is surrounding the heart. The common symptom is chest pain, which is caused when sac layers are rubbing against the heart and inflamed.

Sizing and Forecast

The pericarditis market size has grown strongly in recent years. It will grow from $2.17 billion in 2023 to $2.35 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to increased prevalence of cardiovascular diseases, aging population and higher disease risks, improved understanding of disease pathophysiology, globalization of healthcare, drug development and innovation..

The pericarditis market size is expected to see strong growth in the next few years. It will grow to $3.2 billion in 2028 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increased focus on precision medicine, regulatory support for orphan drugs, patient advocacy and support groups, growing research on inflammatory pathways, global efforts for cardiovascular disease prevention.. Major trends in the forecast period include advances in diagnostic technologies, integration of artificial intelligence in diagnostics, management of recurrent pericarditis, telemedicine in follow-up care, patient education and support, enhancements in imaging technologies..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/pericarditis-global-market-report

Segmentation & Regional Insights

The pericarditis market covered in this report is segmented –

1) By Type: Acute Pericarditis, Chronic Pericarditis, Recurrent Pericarditis
2) By Diagnosis And Treatment: Electrocardiogram (ECG), Echocardiogram, Computerized Tomography (Ct), X-Ray, Medication, Surgical Treatment
3) By Application: Hospitals And Clinics, Medical Institutes, Ambulatory Surgical Centers, Research Organizations

North America was the largest region in the pericarditis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the pericarditis market report during the forecast period. The regions covered in the pericarditis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9170&type=smp

Major Driver Impacting Market Growth

The increasing prevalence of cardiovascular diseases is expected to propel the pericarditis market’s growth going forward. Cardiovascular diseases refer to a term for the conditions affecting the heart or blood vessels. It is usually linked to a buildup of fatty deposits inside the artery and an increased risk of blood clotting. Pericarditis can lead to many cardiovascular diseases or death in extreme cases if it is not treated, so increasing rates of cardiovascular diseases propel the market. For instance, in October 2022, according to an article shared by the Centers for Disease Control and Prevention, a US-based national public health agency, every 40 seconds, a heart attack occurs in the United States. About 805,000 Americans experience a heart attack each year. One in five heart attacks is quiet, the victim is unaware of the damage that has been done. Smoking, high blood pressure, and high cholesterol are major risk factors for heart disease. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the pericarditis devices market.

Key Industry Players

Major companies operating in the pericarditis market are developing innovative products such as therapies for recurrent pericarditis to meet larger customer bases, more sales, and increase revenue. Therapy for recurrent pericarditis refers to the medical interventions and treatment strategies aimed at managing and preventing the recurrence of inflammation of the pericardium, the thin sac surrounding the heart. For instance, in March 2021, Kiniksa Pharmaceuticals Ltd., a Bermuda-based biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval for ARCALYST. Distinguished by its distinctive characteristics, this therapy is a weekly subcutaneously-injected recombinant fusion protein designed to obstruct interleukin-1 alpha (IL-1α) and interleukin-1 beta (IL-1β) signaling. It is specifically developed for treating recurrent pericarditis and mitigating the risk of recurrence in adults and adolescents aged 12 years and older. The trial data demonstrated that the use of ARCALYST brought about clinically meaningful improvements, addressing a significant unmet medical need in recurrent pericarditis. Notably, there were rapid and sustained reductions in both reported pain and inflammation, evident as early as after the initial dose. The therapy exhibited a median time treatment response of 5 days, accompanied by an impressive 97% treatment response rate.

The pericarditis market report table of contents includes:

1. Executive Summary

2. Pericarditis Market Characteristics

3. Pericarditis Market Trends And Strategies

4. Pericarditis Market – Macro Economic Scenario

 

5. Global Pericarditis Market Size and Growth

…..

31. Global Pericarditis Market Competitive Benchmarking

32. Global Pericarditis Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Pericarditis Market

34. Pericarditis Market Future Outlook and Potential Analysis

 

35. Appendix

Explore the trending research reports from TBRC:

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model